Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-041046
Filing Date
2025-08-22
Accepted
2025-08-22 17:22:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 slrxatmprospectus.htm 424B5 377830
2 prospectusa.jpg GRAPHIC 14136
  Complete submission text file 0001628280-25-041046.txt   398548
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266589 | Film No.: 251247250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)